Overview DarioHealth has launched its Integrated GLP-1 Program, the first commercial offering from its collaboration with Beluga Health, combining clinical evaluation, prescribing, and...
Overview The News DarioHealth has partnered with Beluga Health to create an integrated model for longitudinal care, population health, and quality improvement. The collaboration combi...
Overview The News DarioHealth has entered into an agreement with a major health insurer in Arizona through its strategic channel partnership with Amwell, making its cardiometabolic so...
Overview The News DarioHealth announced that one of the five largest U.S. health insurers has expanded its partnership with the company by adding Dario’s AI-powered hypertension...
Overview The News DarioHealth presented four studies at the American Diabetes Association Scientific Sessions demonstrating the clinical and economic impact of sustained eng...
Overview The News DarioHealth announced that Solera Health has expanded its digital health offerings on the platform to include Dario’s broader hypertension program. The program...
Overview The News DarioHealth announced the publication of a peer-reviewed study in JMIR Formative Research evaluating the real-world impact of its digital behavioral&n...
Overview The News DarioHealth announced the publication of a peer-reviewed study in Frontiers in Digital Health analyzing real-world data from 22,414 adults with type 2...
DarioHealth Expands Oral GLP-1 Support as Employers and Health Plans Seek Better Real-World Outcomes
Overview The News DarioHealth announced increasing demand from employers and health plans for its digital health solution supporting oral GLP-1 therapy. As oral formulations may deliv...
Overview The News DarioHealth announced that its research portfolio has surpassed 100 scientific studies, including peer-reviewed journal publications and conference abstracts. The co...
